Clinical Trial Update: Stereotactic Body Radiotherapy and NALIRIFOX for Locally Advanced Pancreatic Cancer: A Prospective Clinical Trial [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov entry describes a Phase 2 prospective trial combining stereotactic body radiotherapy with the NALIRIFOX regimen for locally advanced pan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• FLUOROURACIL (Fluorouracil)
• Leucovorin (folinic acid)
• Onivyde (irinotecan hydrochloride liposome injection)

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: Pancreatic Cancer | Phase 2 | Status: NOT_YET_RECRUITING